Continuous simulation mathematical models are proposed for two different epidemic situa tions : Hepatitis B in a cohort of newborns followed for life, and one of the danger groups in the current AIDS epidemic. The paper describes the rationale behind the systems of differential equations used to model both situ ations, and the way to test alternative policies, such as vaccination, preventive measures, or the effects of new drugs on AIDS.
Kermack, W.O. and McKendrick, A.G. "A Contribution to the Mathematical Theory of Epidemics." Proceedings of the Royal Society of Edinburgh, Vol. 115, pp 700-721, 1927.
2.
Alfonseca, M. , Pulido, E., Lara , J. and Orosco, R. "OOCSMP: An Object-Oriented Simulation Language ." Proceedings of the 9th European Simulation Symposium, ESS'97, SCS, Erlangen, Germany, pp 44-48, 1997.
3.
Anderson, R.M. and May, R.M.Infectious Diseases Of Humans, Dynamics and Control. Oxford University Press, Oxford, 1991.
4.
Salleras, L., Bruguera, M., Vidal , J., et al. "Prevalence of Hepatitis B Markers in the Population of Catalonia (Spain)." European Journal of Epidemiology, Vol. 8, pp 640-644, 1992.
5.
Jager, J.C. and Ruitenberg, E.J. (eds). AIDS Impact Assessment, Modelling and Scenario Analysis. Elsevier, Amsterdam, 1992.
6.
Brookmeyer, R. and Gail, M.H.AIDS Epidemiology: A Quantitative Approach . Oxford University Press, New York , 1994.
7.
Dangerfield, B.C. and Roberts, C.A. "Relating a Transmission Model of AIDS Spread to Data: Some International Comparisons." In Models for Infectious Human Diseases: Their Structure and Relation to Data , V. Isham and G. Medley (eds.), Cambridge University Press, pp 473-476, 1996.
8.
Jager, J.C. and Ruitenberg, E.J. "Multinational Scenario Analysis Concerning Epidemiological Social and Economic Impact of HIV/AIDS on Society." Final Report of the EC Concerted Action, Contract Number BMH1-CT94-1723, 1997.
9.
Bruguera, M. and Sanchez Tapias , J.M. "Epidemiología de la Hepatitis B en España." Medicina Clinica (Barcelona), Vol. 95, pp 470-475, 1990.
10.
Lee, C.Y. , et al. "Low Dose Hepatitis B Vaccine."Lancet, Vol. 1989:2, pp 860-861, 1989.
11.
Torrea, J.L. and Garuz, R. "Efectividad de la Vacunación Universal Frente al virus Hepatitis B." Simulación con un Modelo Matemático, Gaceta Sanitaria, Vol. 8, pp 294-303, 1994.
12.
Garuz, R. , Torrea, J.L., Arnal , J.M., et al. "Vaccination Against Hepatitis B Virus In Spain: A Cost-Effectiveness Analysis."Vaccine, Vol. 15, No. 15, pp 1652-1660, 1997 .
13.
Bailey, N.T.J. and Heisterkamp, S.H."Preliminary Review on the Mathematical Models and Data Used for the Baseline Analysis 1995, EU Concerted Action, Multinational Scenario Analysis Concerning Epidemiological Social and Economic Impacts of HIV/AIDS on Society." Report BMH1-CT-941723, which is part of the Biomedical and Health Research Programme (BIOMED) of the European Union, 1995.
14.
Sida. " Epidemiología del SIDA en España. Situación en el Contexto Mundial." Ministerio de Sanidad y Consumo, Secretaría del Plan Nacional sobre el SIDA , 1995.
15.
Rowley, J.T. and Anderson, R.M. "Modeling the Impact and Cost-Effectiveness of HIV Prevention Efforts." AIDS, Vol. 8, pp 539-548, 1994.
16.
Jager, J.C. , Heisterkamp, S.H., Brookmeyer , R. "AIDS Surveillance and Prediction of the HIV and AIDS Epidemic: Methodological Developments." AIDS, Vol. 7, Supp. 1, pp S67-S71, 1993.
